搜索临床试验以:PARP inhibitors
总计64383个结果
-
National Cancer Institute (NCI)完全的
-
Nanfang Hospital of Southern Medical UniversityNovartis; Major Science and Technology Special Project of China Twelfth-Five-Year Project未知
-
Cancer Research UK完全的乳腺癌 | 卵巢癌 | brca1突变携带者 | brca2突变携带者英国
-
SanofiBreast Cancer Research Foundation完全的
-
Sanofi完全的鳞状细胞肺癌加拿大, 比利时, 西班牙, 美国, 法国, 德国, 匈牙利, 以色列, 意大利, 卢森堡, 荷兰, 波兰, 罗马尼亚, 英国
-
The University of Texas Health Science Center at...撤销
-
National Cancer Institute (NCI)完全的IV 期乳腺癌 | 复发性乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | 雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌 | 男性乳腺癌 | 成人实体瘤美国
-
National Cancer Institute (NCI)完全的
-
AstraZenecaKuDOS Pharmaceuticals Limited完全的
-
AstraZenecaKuDOS Pharmaceuticals Limited完全的
-
Faeth TherapeuticsGOG Foundation尚未招聘
-
Zhou ChengzhiGuangdong Provincial Hospital of Traditional Chinese Medicine; Sun Yat-sen University; Hunan Cancer... 和其他合作者尚未招聘小细胞肺癌
-
University of MelbourneMonash University; University of Adelaide; University of Sydney; The University of New South Wales; Menzies School of Health Research 和其他合作者尚未招聘
-
Guangzhou University of Traditional Chinese MedicineJiangsu Province Hospital of Traditional Chinese Medicine; The First Affiliated Hospital, Guangzhou...尚未招聘
-
Merck Sharp & Dohme LLCGOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT)尚未招聘
-
Shanghai Chest HospitalNovartis; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; BeiGene尚未招聘
-
Memorial Sloan Kettering Cancer CenterTransThera Sciences招聘中
-
Kocaeli City HospitalHealth Institutes of Türkiye (TUSEB)尚未招聘
-
Stemline Therapeutics, Inc.尚未招聘
-
Yongyong MA招聘中